2006 Doctors Pharmacy 
Drug Channels
APRIL 26, 2022
Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day! Next week, I'll be live and in-person at Asembia's Specialty Pharmacy Summit. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. You can also find my daily posts at @DrugChannels on Twitter , where I have more than 13,800 followers.
Drug Channels
SEPTEMBER 19, 2023
Today, the House Committee on Oversight and Accountability will hold a hearing with a subtle and not-at-all pejorative title: The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part II: Not What the Doctor Ordered. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Read on for what I say.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
NOVEMBER 24, 2020
In this issue: Rebate rule redux Most Favored Nation and healthcare benchmarking Amazon’s pharmacy customer opportunity Drug spending realities updated GPO consolidation Plus, I congratulate Dirk Rodgers of RxTrace on his retirement. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. to 1:15 p.m. to 1:15 p.m.
Drug Channels
DECEMBER 3, 2024
Below, I do a wicked deep dive into the data and highlight crucial implications about spending, profits, pharmacies, plans, patients, program integrity, and more. And don't forget to put on your ruby slippers and hear from Doctor of Thinkology Adam J. There are important limitations to these data. All rights reserved.
Agency IQ
SEPTEMBER 15, 2023
In 2006, the FDA amended its final rule to add phenylephrine bitartrate (an effervescent formulation) to phenylephrine hydrochloride as GRASE over-the-counter nasal decongestant products included in that final monograph. Another meta-analysis was conducted by industry in 2007, which came to the opposite conclusion.
Drug & Device Law
FEBRUARY 10, 2023
That issue, in turn, involves product identification (another problem in MDLs) and a pointer for pharmacies that want to avoid being involved in pharmaceutical litigation. That manufacturer had relinquished all of its rights to Zantac in December 2006 – eight years before plaintiff began using it in 2014.
Expert insights. Personalized for you.
82 
Let's personalize your content